Prevalence of oral corticosteroid use in the German severe asthma population.
Christian TaubePeter BramlageAnnette HoferDörte AndersonPublished in: ERJ open research (2019)
The analyses show that OCSs are frequently prescribed in patients receiving HD-ICS/LABAs because of severe asthma and are they are frequently associated with adverse effects commonly reported with steroid usage. These data support a necessary change in severe asthma treatment, which is reflected in current treatment guidelines.